Suppr超能文献

表皮生长因子受体、c-erbB-2和p53在喉上皮增生性病变中的过表达

Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.

作者信息

Gale N, Zidar N, Kambic V, Poljak M, Cör A

机构信息

Institute of Pathology, Medical Faculty, University of Ljubljana, Slovenia.

出版信息

Acta Otolaryngol Suppl. 1997;527:105-10. doi: 10.3109/00016489709124048.

Abstract

An immunohistochemical analysis of overexpression of epidermal growth factor receptor (EGFR), c-erbB-2, and p53 proteins was performed on 43 biopsies of laryngeal epithelial hyperplastic lesions (EHLL), classified according to the Kambic-Lenart classification, and in 11 cases of laryngeal carcinoma (SCCL). The aim of the present study was to determine whether there is a correlation between the staining patterns of these proteins and different grades of EHLL, and to reveal their possible prognostic value. We compared the staining patterns of atypical hyperplasia adjacent to cancer with the same type of lesions which have not turned malignant. p53 and EGFR overexpressions were detected in 28/54 (52%) and 33/54 cases (61%), respectively, and tend to increase with the degree of epithelial changes. The intensity of staining in various grades of EHLL adjacent to cancer was more pronounced than the same type of lesions which have not progressed to cancer. c-erbB-2 was weakly positive in the majority of cases, and changed from predominantly membranous in simple hyperplasia to cytoplasmic staining in abnormal and atypical hyperplasias. There was no significant statistic correlation between the amount of positive cells for all proteins and the grade of epithelial abnormalities. We conclude that the overexpression of each biomarker itself adds little predictive value over routine histomorphology, and cannot be regarded as a reliable prognostic factor for EHLL. However, the histologic characteristics of atypical hyperplasia together with the immunostaining patterns of EGFR and p53 up to two-thirds or more of the epithelial thickness could be considered a reliable pattern which correlates with the progression to cancer.

摘要

对43例根据坎比奇-莱纳特分类法分类的喉上皮增生性病变(EHLL)活检标本以及11例喉癌(SCCL)病例进行了表皮生长因子受体(EGFR)、c-erbB-2和p53蛋白过表达的免疫组织化学分析。本研究的目的是确定这些蛋白的染色模式与不同级别的EHLL之间是否存在相关性,并揭示其可能的预后价值。我们比较了癌旁非典型增生与未恶变的同类型病变的染色模式。分别在28/54例(52%)和33/54例(61%)中检测到p53和EGFR过表达,且其表达倾向于随着上皮变化程度增加。癌旁不同级别的EHLL中的染色强度比未进展为癌的同类型病变更明显。在大多数病例中,c-erbB-2呈弱阳性,且从单纯增生时主要为膜性染色变为异常增生和非典型增生时的胞质染色。所有蛋白的阳性细胞数量与上皮异常级别之间无显著统计学相关性。我们得出结论,每种生物标志物本身的过表达相对于常规组织形态学几乎没有增加预测价值,不能被视为EHLL的可靠预后因素。然而,非典型增生的组织学特征以及EGFR和p53免疫染色模式达到上皮厚度的三分之二或更多可被视为与癌症进展相关的可靠模式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验